Levee Medical

Funding and NIH signals

• SEC Form D raise Raised $12.5M in debt securities (Form D filed Nov 12, 2025; amended May 5, 2026). SEC Form D 0001877814-25-000002 (Nov 12, 2025)
  Evidence (1 event)

  • Nov 12, 2025 · SEC Form D 0001877814-25-000002
    Name of Issuer: Levee Medical, Inc.; CIK: 1877814; Address: Durham, NC; Submission type: D; Filing date: 2025-11-12; Industry Group: Other Health Care; Date of First Sale: 2025-10-31; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4458934; Federal exemptions: 06b || Name of Issuer: Levee Medical, Inc.; CIK: 1877814; Address: Durham, NC; Submission type: D/A; Filing date: 2026-05-05; Industry Group: Other Health Care; Date of First Sale: 2025-10-31; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 12500000; Total Amount Sold: 12500000; Federal exemptions: 06b
• NIH award NIH awarded $912K (SBIR Phase II 1R44CA314945-01, new, notice Jul 29, 2026). NIH RePORTER 1R44CA314945-01 (Jul 29, 2026)
  Evidence (1 event)

  • Jul 29, 2026 · NIH RePORTER 1R44CA314945-01
    Organization: LEVEE MEDICAL INC; City/State: RALEIGH, NC; Project number: 1R44CA314945-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-29; FY total cost (award amount): 912125; Administering IC: National Cancer Institute; Project title: Novel Scaffold for Mitigating Post-Prostatectomy Urinary Incontinence; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals